The University of Chicago Header Logo

Connection

Hans Schreiber to Neoadjuvant Therapy

This is a "connection" page, showing publications Hans Schreiber has written about Neoadjuvant Therapy.
Connection Strength

0.136
  1. Neoadjuvant PD-1 Immune Checkpoint Blockade Reverses Functional Immunodominance among Tumor Antigen-Specific T Cells. Clin Cancer Res. 2020 02 01; 26(3):679-689.
    View in: PubMed
    Score: 0.136
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.